Atlas Trials

Trilaciclib in Combination With Chemotherapy in Patients With CDK4/6-Dependent Solid Tumors

Clinical trial NCT07490236 · RECRUITING

Trial details

NCT number
NCT07490236
Sponsor
Hebei Medical University Fourth Hospital
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
TrilaciclibCDK4/6-dependent Solid Tumors
Start date
2023-01-01
Primary completion
2027-08-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.